Page last updated: 2024-08-22

lutetium and gastrin-releasing peptide

lutetium has been researched along with gastrin-releasing peptide in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Nunn, AD; Panigone, S	1
De Araújo, EB; Massicano, AV; Mengatti, J; Pujatti, PB; Santos, JS	1
Breeman, WA; de Blois, E; de Jong, M; Krenning, EP; Maina, T; Marsouvanidis, PJ; Melis, M; Nock, BA	1

Reviews

1 review(s) available for lutetium and gastrin-releasing peptide

Article	Year
Lutetium-177-labeled gastrin releasing peptide receptor binding analogs: a novel approach to radionuclide therapy. The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of..., 2006, Volume: 50, Issue:4 Topics: Antibodies, Monoclonal; Drug Delivery Systems; Gastrin-Releasing Peptide; Humans; Lutetium; Neoplasms; Radioisotopes; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Bombesin	2006

Article

Year

Lutetium-177-labeled gastrin releasing peptide receptor binding analogs: a novel approach to radionuclide therapy.

The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of..., 2006, Volume: 50, Issue:4

Topics: Antibodies, Monoclonal; Drug Delivery Systems; Gastrin-Releasing Peptide; Humans; Lutetium; Neoplasms; Radioisotopes; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Bombesin

2006

Other Studies

2 other study(ies) available for lutetium and gastrin-releasing peptide

Article	Year
Development of a new bombesin analog radiolabeled with lutetium-177: in vivo evaluation of the biological properties in Balb-C mice. Cellular and molecular biology (Noisy-le-Grand, France), 2010, May-10, Volume: 56, Issue:2 Topics: Animals; Bombesin; Chromatography, Thin Layer; Gastrin-Releasing Peptide; Ligands; Lutetium; Male; Mice; Mice, Inbred BALB C; Peptides; Radioisotopes; Radiopharmaceuticals; Temperature; Time Factors; Tissue Distribution; Tomography, Emission-Computed, Single-Photon	2010
In vivo enzyme inhibition improves the targeting of [177Lu]DOTA-GRP(13-27) in GRPR-positive tumors in mice. Cancer biotherapy & radiopharmaceuticals, 2014, Volume: 29, Issue:9 Topics: Animals; Cell Line, Tumor; Gastrin-Releasing Peptide; Glycopeptides; Heterografts; Humans; Lutetium; Male; Mice; Mice, Nude; Neprilysin; Peptide Fragments; Prostatic Neoplasms; Protease Inhibitors; Radioisotopes; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Bombesin; Tissue Distribution	2014

Article

Year

Development of a new bombesin analog radiolabeled with lutetium-177: in vivo evaluation of the biological properties in Balb-C mice.

Cellular and molecular biology (Noisy-le-Grand, France), 2010, May-10, Volume: 56, Issue:2

Topics: Animals; Bombesin; Chromatography, Thin Layer; Gastrin-Releasing Peptide; Ligands; Lutetium; Male; Mice; Mice, Inbred BALB C; Peptides; Radioisotopes; Radiopharmaceuticals; Temperature; Time Factors; Tissue Distribution; Tomography, Emission-Computed, Single-Photon

2010

In vivo enzyme inhibition improves the targeting of [177Lu]DOTA-GRP(13-27) in GRPR-positive tumors in mice.

Cancer biotherapy & radiopharmaceuticals, 2014, Volume: 29, Issue:9

Topics: Animals; Cell Line, Tumor; Gastrin-Releasing Peptide; Glycopeptides; Heterografts; Humans; Lutetium; Male; Mice; Mice, Nude; Neprilysin; Peptide Fragments; Prostatic Neoplasms; Protease Inhibitors; Radioisotopes; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Bombesin; Tissue Distribution

2014